Related content

Ischaemia-modified albumin in pulmonary hypertension

By Sbarouni Eftihia   Georgiadou Panagiota   Manginas Athanassios   Panagiotakos Demosthenes   Karavolias George K.   Voudris Vassilis  

Biomarkers, Vol. 15, Iss. 3, 2010-05 ,pp. : 238-242

Informa Healthcare

Access to resources Recommend Favorite

Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patients

By Ulasli Sevinc   Eyuboglu Fusun   Verdi Hasibe   Atac Fatma  

Molecular Biology Reports, Vol. 40, Iss. 10, 2013-10 ,pp. : 5625-5633

Springer Publishing Company

Access to resources Recommend Favorite

Gene therapy for pulmonary arterial hypertension: is a cure in sight?

By Mathew Rajamma  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 2, 2011-02 ,pp. : 129-131

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for pulmonary hypertension: prospects and challenges

By Reynolds Paul N  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 2, 2011-02 ,pp. : 133-143

Informa Healthcare

Access to resources Recommend Favorite

Protection of oral hydrogen water as an antioxidant on pulmonary hypertension

By He Bin   Zhang Yufeng   Kang Bo   Xiao Jian   Xie Bing   Wang Zhinong  

Molecular Biology Reports, Vol. 40, Iss. 9, 2013-09 ,pp. : 5513-5521

Springer Publishing Company

Access to resources Recommend Favorite